Emerging Next-Generation Immunohistochemical Markers: Mainline Diagnostic Applications, A Couple Useful Tricks, and a Few Pitfalls

June 14, 2023 at 11:00am Eastern Time

At the end of the webinar, participants will be able to:

1. Discuss “Limits of Detection” (LOD) for antibodies in general, and how they are obtained.
2. Be able to distinguish the clinical importance of clinical Low Her2 versus Positive Her2.
3. Describe practice changes you will make in order to ensure proper interpretation of clinical IHC tests.

Speaker: Andrew Bellizzi